Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/43801
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorByard, R.-
dc.date.issued2007-
dc.identifier.citationJournal of Forensic Sciences, 2007; 52(5):1164-1170-
dc.identifier.issn0022-1198-
dc.identifier.issn1556-4029-
dc.identifier.urihttp://hdl.handle.net/2440/43801-
dc.description.abstractNeurofibromatosis types 1 and 2 are inherited neurocutaneous disorders characterized by a variety of manifestations that involve the circulatory system, the central and peripheral nervous systems, the skin, and the skeleton. Significant reduction in lifespan occurs in both conditions often related to complications of malignancy and hypertension. Individuals with these conditions may also be the subject of medicolegal autopsy investigation if sudden death occurs. Unexpected lethal events may be associated with intracranial neoplasia and hemorrhage or brainstem compression. Vasculopathy with fibrointimal proliferation may result in critical reduction in blood flow within the coronary or cerebral circulations, and aneurysmal dilatation may be associated with rupture and life-threatening hemorrhage. An autopsy approach to potential cases should include review of the history/hospital record, liaison with a clinical geneticist (to include family follow-up), a full external examination with careful documentation of skin lesions and nodules, measurement of the head circumference in children, photography, possible radiologic examination, a standard internal autopsy examination, documentation of the effects of previous surgery and/or chemo/radiotherapy, examination for specific tumors, specific examination and sampling of vasculature (renal, cerebral, and cardiac), formal neuropathologic examination of brain and spinal cord, possible examination of the eyeballs, examination of the gastrointestinal tract, histology to include tumors, vessels, gut, and bone marrow, toxicological testing for anticonvulsants, and sampling of blood and tissue for possible cytogenetic/molecular evaluation if required.-
dc.description.statementofresponsibilityRoger W. Byard-
dc.language.isoen-
dc.publisherAmer Soc Testing Materials-
dc.source.urihttp://dx.doi.org/10.1111/j.1556-4029.2007.00512.x-
dc.subjectHumans-
dc.subjectNeurofibromatoses-
dc.subjectDeath, Sudden-
dc.subjectAutopsy-
dc.subjectLife Expectancy-
dc.subjectForensic Pathology-
dc.subjectComorbidity-
dc.titleForensic considerations in cases of neurofibromatosis - An overview-
dc.typeJournal article-
dc.identifier.doi10.1111/j.1556-4029.2007.00512.x-
pubs.publication-statusPublished-
dc.identifier.orcidByard, R. [0000-0002-0524-5942]-
Appears in Collections:Aurora harvest
Pathology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.